Overview

Phase II Trial of Standard Chemotherapy (Carboplatin & Paclitaxel) +Various Proton Beam Therapy (PBT) Doses

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to study which dose of proton beam therapy (PBT) for unresectable stage 2/3 Non-Small Cell Lung Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel